ARTICLE | Distillery Therapeutics
Other
March 8, 2017 6:33 PM UTC
Cell culture and mouse studies suggest a synthetic glycolipid adjuvant could help improve the efficacy of vaccines for infectious diseases with less toxicity than conventional adjuvants. In human mono...
BCIQ Company Profiles
BCIQ Target Profiles
Mycobacterium tuberculosis secreted antigen 85-A (fbpA) (Ag85A)